![]() |
Back |
|
Neuropharmacology & Analgesia, Immuno-Molecular Pharmacology, Biochemical-Systemic Pharmacology |
RESEARCH/REVIEW PUBLICATIONS (SCI/IF)
PUBLICATIONS (NON-SCI)
PATENTS
|
PRESENTATIONS/CONFERENCES/WORKSHOPS 1. Salman Khan. Pain and Nanoparticles: molecular targets and mechanism. Fall International Convention of Pharmaceutical Society of Korea 21-23 October-2020, Korea {Virtual}. 2. Salman Khan. Vascular dysfunction and potential role of anti-inflammation in 3. Salman Khan. Pharmacological evaluations and drug discovery from naturally isolated compound. 1st National Conference on Current Updates in Pharmacy Profession and Research, July 29~30, 2019, COMSATS University Abbottabad, Pakistan. 4. Salman Khan. Pharmacological Mechanism Underlying Anti-inflammatory, Anti-nociceptive and Neuroprotective Activities of Anomalin. 3rd International conference Recent Advancement in Pharmaceutical Research and Drug Delivery, February 19~20, 2019. QAU, Islamabad, Pakistan. 5. Salman Khan. Approach toward new drug development based on pharmacological evaluation from naturally isolated compounds. Proceeding of the 47th Annual Meeting of the Korean Society of Pharmacognosy, The 10th KSP-JSP-CJP joint symposium, Ehwa Women University, Seoul, December 22-23, 2018, South Korea 6. Salman Khan. Predominant role of vascular dysfunction and potential of anti-inflammation in alleviation of neuropathic pain. Asia PharmII (The 2nd Asian conference of Pharmaceutical Sciences, Jun 2-22, 2017, Seoul, Korea. 7. Salman Khan, RJ Choi, JH Lee, YS Kim. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative, anomalin in animal and cellular models. Proceeding of the 46th Annual Meeting of the Korean Society of Pharmacognosy, Seoul, December 03, 2015, South Korea. 8. Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11th CGCM meeting, August 20~24, 2012, Macau. 9. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, A. Tosun, Y. Shik Kim. Anomalin, pyranocoumarin inhibits LPS-induced expression of inflammatory mediators via NF-κB and MAP-kinase signaling pathways. 10th CGCM meeting August 26~ 28, 2011, Shanghai, China. 10. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan. 11. Salman Khan, E. M. Shin, D-U. Lee, Y. S. Kim. Bioactivity guided evaluation of sesquiterpenes as an anti-inflammatory activity isolated from Cyperus rotundus L: Effect of chemical structures and cellular signaling pathway. 9th CGCM meeting, 2010. Hong Kong.
POSTER PRESENTATIONS/ CONFERENCES
1. Salman Khan. COMSTECH online course entitled "Protozoan ’Drug’ Discovery: Old Drugs, New Targets and Mining for Novelty, Delivered by Prof. Dr. Paul W. Denny, August 6th, 2021. 2. Salman Khan. COMSTECH webinar “Online Meeting on Recent Developments in Drug Discovery and Medicinal Chemistry" on July 26-27, 2021. 3. Salman Khan. Online Meeting on Recent Developments in Drug Discovery and Medicinal Chemistry" on July 26-27, 2021, Islamabad, Pakistan 4. Salman Khan. 2nd Global Virtual Conference on Neurodegenerative Diseases (GVCND-2021). Central European (Berlin, Rome, Stockholm, Vienna) January 28, 2021. 5. B Shal, A Khan, A Ullah Khan, Salman Khan. Neuroprotective effect of a triterpenoid derivative against CCl 4 -induced behavior alterations by targeting VEGF/BDNF and caspase-3 in mice. Autumn Meeting for Young Chemists in Biomedical Sciences (AMYC BIOMED) organized by Department of Excellence of Pharmacy (University of Naples Federico II. Italy), Oct 13-14, 2020. 6. A Khan, B Shal, A Ullah Khan, T Bibi, Salman Khan. Phytosteroid ameliorates the progression of motor/sensory symptoms in a mouse model of multiple sclerosis. Autumn Meeting for Young Chemists in Biomedical Sciences (AMYC BIOMED) organized by Department of Excellence of Pharmacy (University of Naples Federico II, Italy), Oct 13-14, 2020. 7. Salman Khan. 4th International Conference (Virtual) titled “Integrative multidisciplinary nanomedicine: a game changing strategy for emerging infectious disease” Department of Pharmacy, Quaid-i-Azam University in collaboration with ORIC QAU, Islamabad, Pakistan. October 10, 20120. 8. B Shal, A Khan, M Naveed, YS Kim, Salman Khan. Anti-anxiety and anti-depressant effect of a triterpenoid derivative against bacteria-induced behavioral alterations. in 6th international conference on Drug Development-Natural and Synthetic: Current approaches and emerging trends for the development and discovery of drugs being hosted by Centre for Advanced Drug Research (CADR), COMSATS University, Abbottabad on Nov 29-30, 2019. 9. A Ullah Khan, A Muhammad, A Khan, B Shal, MN Ahmad, A Aziz, Salman Khan. The newly synthesized N-Benzylidene-4-(2-HydroxyNaphthalene-1-yl) Diazenyl) Hydrazides (1-2) (NCHDH and NTHDH) compounds attenuates LPS-induced septicemia and multi-organ failure through HSP70/90 proteins and Nrf2 signaling. 6th international conference on Drug Development-Natural and Synthetic: Current approaches and emerging trends for the development and discovery of drugs being hosted by Centre for Advanced Drug Research (CADR), COMSATS University, Abbottabad on Nov 29-30, 2019. 10. A Khan, B Shal, A Ullah Khan, IU Haq, Salman Khan. Isowithametelin and Ajugarin-1 protects hippocampal neuronal cells against H2O2-induced damage through suppression of oxidative stress. (6th international conference on Drug Development-Natural and Synthetic: Current approaches and emerging trends for the development and discovery of drugs being hosted by Centre for Advanced Drug Research (CADR), COMSATS University, Abbottabad on Nov 29-30, 2019. 11. A Khan, B Shal, M Naveed, YS Kim, Salman Khan. Anxiolytic and antidepressant-like effects of matrine through inhibition of JNK-mediated inflammatory, ROS, and apoptotic signaling in animal model of burn injury. 3rd International Conference on “Recent Advancement in Pharmaceutical Research and Drug Delivery”, Department of Pharmacy, Quaid-i-Azam University, Islamabad on Feb 19-20, 2019. 12. Salman Khan. International Pharmacy Conference and Exhibition (IPCE), Jun 18~19, 2019, University of Swabi, KPK, Pakistan 13. Salman Khan. Pharmacological evaluations and drug discovery from naturally isolated compound. 1st National Conference on Current Updates in Pharmacy Profession and Research, July 29~30, 2019 COMSATS University Abbottabad, Pakistan. 14. S Khalid, M Ziaullah, A Khan, R Afridi, h Rasheed, A Khan, H Ali, YS Kim, Salman Khan. Antihyperalgesic and antiallodynic properties of honokiol in acute and chronic models of inflammatory pain. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 15. A Khan, M Ziaullah, R Afridi, H Rasheed, S Khalid, H Ullah, YS Kim, Salman Khan. Anti-nociceptive properties of 25-MHA in CFA and carrageenan-induced in animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan 16. H Rasheed, R Afridi, A Khan, M Ziaullah, S Khalid, A Atiq, H kashif, MN Ahmad, YS kim, Salman Khan. Anti‑infammatory and analgesic activities of 2‑(5‑me rcapto‑1,3,4‑oxadiazol‑2‑yl)‑N‑propylbenzenesulphonamide (MOPBS) in rodents. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 17. A Atiq, B Shal, M Naveed, A Khan, S Zeeshan, Salman Khan. Pharmacological evaluation of Silver sulfadiazine nanoparticles loaded Alovera encapsulated film on animal mode of wounds. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 18. M Naveed, S Zeeshan, A Khan, B Shal, A Atiq, Salman Khan. Anti-inflammatory, analgesic and antipyretic activities of newly synthesized hetroleptic palladium (II) complexes. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 19. S Zeeshan, M Naveed, A Khan, B Shal, H Rasheed, Salman Khan. Anti-inflamamtory and analgesic effect of novel palladium (II) complexes on animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan 20. A Khan, B Shal, M Naveed, A Atiq, S Zeeshan, Salman Khan. Matrine ameliorates anxiety and depressive like behavior in carbon tetrachloride and burn-induced animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 21. B Shal, A Khan, M Naveed, A Atiq, S Zeeshan, Salman Khan. Evaluation of pharmacological potential of 25-MHA in LPS and CCl4-induced anxiety and depression models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 22. R Afridi, H Rasheed, A Khan, S Khalid, Z ullah, B Shal, H Jabeen, YS Kim, Salman Khan. Antihyperalgesic properties of Flavone derivative Poncirin in acute and chronic inflammatory pain models in mice. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan. 23. M Zeeshan, H Ali, M Arshad, MI Khan, M Mukhtar, Salman Khan. Design. Characterization and kinetics study of Glycyrrhizic acid loaded pH-sensitive PLGA nanoparticles for the potential drug targeting in inflammatory bowel disease. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan 24. Salman Khan. 2nd international conference on recent innovations in pharmaceutical sciences (ICRIPS-2017), Organized by Riphah Institute of Pharmaceutical Sciences, November 15-16, 2017, Islamabad, Pakistan. 25. Salman Khan, O. Shehzad, J. Chun, and Y. S. Kim. Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, CREB and MAPKs signaling cascades. Korean Society of Pharamcognosy 2012. 06. (Seoul, Korea). 26. Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11th CGCM meeting August 20~24, 2012, Macau. 27. Salman Khan, E. M. Shin, S. W. Baek, J. Kim, Y. S. Kim. Novel labdan diterpene derivative isolated from Leonurus japonicum as a function of anti-inflammatory activity in LPS-stimulated RAW 264.7 cells. 9th CGCM meeting, 2010, Hong Kong. 28. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. S. Kim. Anti-inflammatory and anti-NF-κB effects of anomalin isolated from the root of Saposhnikovia divaricata in LPS-stimulated RAW264.7 macrophages. 9th CGCM meeting, 2010, Hong Kong. 29. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan. 30. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Investigation of flow pattern and volumetric oxygen transfer coefficient (KLa) for new bioreactors equipped with centrifugal impellers. Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea. 31. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Treatment of Brewery Waste for the Improved Production of Bacterial Cellulose by a Gluconacetobacter Strain, Young Asian Biochemical Engineers’s Community 2007, (YABEC), Japan. 32. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Evaluation of Autolyzed waste of beer fermentation broth as a basal medium for the production of bacterial cellulose and oligosaccharides Gluconacetobacter hansenii, Korean Institute of Chemical Engineers 2007 (KIChE-2007), Daejon, South Korea. 33. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production and structure feature of bacterial cellulose using nano-bubble system, Young Asian Biochemical Engineers’s Community 2008 (YABEC-2008), Japan. 34. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production of bacterial cellulose using waste from beer fermentation broth in shaking cultivation, Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jeju do, S.Korea.
35. O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of Bacterial Cellulose membrane by G. hasenii using fed batch cultivation. (Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea.
36. O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of bacterial cellulose in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.
37. O. Shehzad, Salman Khan, T. Khan, J. K. Park, Physico-Chemico-Mechanical characteristics of bacterial cellulose produced in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.
|
Salman Khan, Y S Kim. Pharmacological Screening of KFDA samples (natural products) for anti-inflammatory, anti-nociceptive and behavioral pharmacological activities. Joint project between College of Pharmacy, Seoul National University, Seoul, Korea and Department of Pharmacy, QAU. From March 15, 2015~ March 10, 2019), Funded by National Research Foundation (NRF), South Korea. Salman Khan (PI), Gul Majid Khan (Co-PI); “Evaluation of phenolic compounds effect on streptozotocin-induced diabetes and related neuropathic pain model in mice”, 2015-2016 HEC, Pakistan (Rs. 419000) Completed) Salman Khan (Co-PI), Ji Zhang. Potential of anti-inflammation in relieving diabetic neuropathy. Neuroinflammation Training Program, McGill University, Montreal, Quebec, Canada, April 01, 2014~ April 30, 2015. (40000USD) Completed. Salman Khan (PI), YS Kim (Co-PI). BK-21-plus, College of Pharmacy, Seoul National University, Seoul, South Korea, 2013~ 2014 (30000USA) Completed. Salman Khan (PI), Hussain Ali (Co-PI). Therapeutic potential of anti-inflammation in attenuation of neurodegenerative diseases: molecular approach toward specific targets (NRPU-submitted to HEC, Pakistan) Hussain Ali (PI), Salman Khan (Co-PI); “Preparation and characterization of drug loaded PLGA/pH- sensitive PLGA-nanoparticles for therapeutic applications”, HEC, Pakistan (ongoing) |